We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$106B
AUM Growth
+$3.52B
(+3.4%)
Cap. Flow
+$5.21B
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
45.25%
Holding
3,801
New
219
Increased
2,152
Reduced
975
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$647M |
| 2 |
Vanguard Total Bond Market
BND
|
+$580M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$328M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$305M |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$250M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$92.5M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$61.7M |
| 4 |
Apple
AAPL
|
+$27.7M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.35% |
| 2 | Financials | 3.91% |
| 3 | Consumer Discretionary | 1.87% |
| 4 | Healthcare | 1.85% |
| 5 | Communication Services | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Array Technologies
ARRY
$818M
| $69.6K | ﹤0.01% |
14,282
+2,121
| +17% | +$13.7K |
|
3302
Journey Medical
DERM
$170M
| $69.4K | ﹤0.01% |
11,764
| – | – |
|
3303
E.W. Scripps
SSP
$274M
| $69.3K | ﹤0.01% |
23,428
-334
| -1% | -$731 |
|
3304
CALL
Intel
INTC
$466B
| $69K | ﹤0.01% |
+20,000
| New | +$438K |
|
3305
Energy Vault
NRGV
$522M
| $68.5K | ﹤0.01% |
98,499
+50
| +0.1% | +$77 |
|
3306
Senseonics Holdings Inc
SENS
$254M
| $67.6K | ﹤0.01% |
5,149
+690
| +15% | +$11.4K |
|
3307
Tilray
TLRY
$479M
| $66.9K | ﹤0.01% |
10,171
| – | – |
|
3308
Atea Pharmaceuticals
AVIR
$379M
| $66.8K | ﹤0.01% |
22,341
| – | – |
|
3309
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
| $65.4K | ﹤0.01% |
+25,046
| New | +$80.8K |
|
3310
Safe Bulkers
SB
$781M
| $64.3K | ﹤0.01% |
+17,434
| New | +$63.5K |
|
3311
Erasca
ERAS
$6.63B
| $64K | ﹤0.01% |
46,695
+24,011
| +106% | +$41.2K |
|
3312
Quad
QUAD
$430M
| $63.3K | ﹤0.01% |
+11,622
| New | +$73.9K |
|
3313
Riverview Bancorp
RVSB
$107M
| $63K | ﹤0.01% |
11,145
| – | – |
|
3314
Cogent Biosciences
COGT
$6.79B
| $62.9K | ﹤0.01% |
+10,494
| New | +$82.3K |
|
3315
Blend Labs
BLND
$409M
| $62.8K | ﹤0.01% |
18,760
+18,369
| +4,698% | +$66.8K |
|
3316
8x8 Inc
EGHT
$247M
| $62.3K | ﹤0.01% |
31,147
-11,369
| -27% | -$29.3K |
|
3317
Precigen
PGEN
$1.93B
| $61.7K | ﹤0.01% |
41,390
+16,213
| +64% | +$25.5K |
|
|
GGN
3318
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
| $60.9K | ﹤0.01% |
13,931
+518
| +4% | +$2.13K |
|
3319
Candel Therapeutics
CADL
$700M
| $60.7K | ﹤0.01% |
+10,742
| New | +$87.8K |
|
3320
PUT
Applovin
APP
$132B
| $60.6K | ﹤0.01% |
25,000
-25,000
| -50% | -$8.62M |
|
3321
Relay Therapeutics
RLAY
$4.02B
| $60.6K | ﹤0.01% |
23,117
-6,415
| -22% | -$25.1K |
|
3322
Pacific Biosciences
PACB
$422M
| $59.9K | ﹤0.01% |
50,797
-46,019
| -48% | -$70.6K |
|
3323
Bumble
BMBL
$367M
| $59.8K | ﹤0.01% |
13,781
-38,211
| -73% | -$249K |
|
3324
Playtika
PLTK
$1.4B
| $59.7K | ﹤0.01% |
11,543
+11,218
| +3,452% | +$70.4K |
|
3325
Aura Biosciences
AURA
$729M
| $59.5K | ﹤0.01% |
10,157
-11,258
| -53% | -$85.2K |
|
Similar funds
Creative Planning's Q1 2025 Portfolio in Review
As of Q1 2025, Creative Planning held 3,801 positions worth $106B, up 3.4% from $103B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $5.21B of net new capital in Q1 2025, opening 219 new positions and adding to 2,152 existing holdings. Its largest new stake was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $250M trimmed.
- Creative Planning's largest Q1 2025 buy was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2025, an estimated $647M increase.
- Creative Planning's biggest Q1 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $250M.
- Creative Planning fully exited Blue Owl Capital Corporation III in Q1 2025, selling an estimated $15.5M.
- Creative Planning's ten largest holdings make up 45% of its $106B portfolio in Q1 2025.
- Creative Planning opened 219 new positions and closed 349 in Q1 2025.
- Creative Planning's portfolio value rose 3.4% quarter-over-quarter to $106B.
Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.